We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets me... Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others. Show more
Zynex Sets First Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo., April 18, 2024 ENGLEWOOD, Colo., April 18, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical...
Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award PR Newswire ENGLEWOOD, Colo., April 2, 2024 ENGLEWOOD, Colo., April 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI...
Zynex Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire ENGLEWOOD, Colo., Feb. 29, 2024 FY 2023 Revenue Increased 17% to $184.3 Million Company Announces Additional $20...
Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call PR Newswire ENGLEWOOD, Colo., Feb. 22, 2024 ENGLEWOOD, Colo., Feb. 22, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative...
Zynex Introduces New Products PR Newswire ENGLEWOOD, Colo., Feb. 20, 2024 ENGLEWOOD, Colo., Feb. 20, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company...
NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Today, Sichenzia Ross Ference Carmel LLP (“SRFC”), a full-service law firm internationally recognized for its securities and litigation practices...
Zynex Receives FDA Clearance for its Next Generation NMES Device PR Newswire ENGLEWOOD, Colo., Feb. 6, 2024 ENGLEWOOD, Colo., Feb. 6, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an...
Zynex Recognized in Top 25 Medical Device Companies for 2024 PR Newswire ENGLEWOOD, Colo., Feb. 2, 2024 ENGLEWOOD, Colo., Feb. 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.76 | -6.2966031483 | 12.07 | 12.3387 | 11.28 | 128499 | 11.85822058 | CS |
4 | -1.6 | -12.393493416 | 12.91 | 13.04 | 11.28 | 121199 | 12.23682851 | CS |
12 | 0.02 | 0.177147918512 | 11.29 | 13.77 | 11.26 | 212250 | 12.40027944 | CS |
26 | 2.93 | 34.9642004773 | 8.38 | 13.77 | 7.04 | 280221 | 10.53566433 | CS |
52 | -0.36 | -3.08483290488 | 11.67 | 14.75 | 6.88 | 332747 | 9.60912653 | CS |
156 | -3.91 | -25.6898817346 | 15.22 | 17.89 | 4.97 | 308343 | 10.26179402 | CS |
260 | 6.01 | 113.396226415 | 5.3 | 29.7271 | 4.97 | 416656 | 13.42588784 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions